Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (91-100 of 369) with videos related to

Pageof 37
Sort By:
Cancer Research|January 15, 1990
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell lineS de Jong, J G Zijlstra, E G de Vries, et al.
Anticancer Research|September 1, 1995
Review of current clinical experience with prolonged (oral) etoposide in cancer treatmentR S de Jong, N H Mulder, D Dijksterhuis, et al.
The Netherlands Journal of Medicine|November 6, 1998
Treatment of special breast cancer patientsH de Graaf, P H Willemse, E G de Vries, et al.
Anticancer Research|December 29, 2000
Effect of specific or random c-DNA priming on sensitivity of tyrosinase nested RT-PCR: potential clinical relevanceA Calogero, G A Hospers, H Timmer-Bosscha, et al.
Journal of the National Cancer Institute|April 5, 1995
Role of the glutathione S-conjugate pump in cisplatin resistanceE G de Vries, M Müller, C Meijer, et al.
Anticancer Research|March 4, 2000
Selective use of preoperative radiotherapy in the treatment of cancer in the lower two thirds of the rectumJ M Ketel, R C Verschueren, N H Mulder, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1986
Evaluation of gastrointestinal toxicity following cytostatic chemotherapyJ M Smit, N H Mulder, D T Sleijfer, et al.
Journal of Pharmaceutical Sciences|May 1, 1992
Pharmacokinetics of parenteral 13-cis-retinoic acid formulations in ratsH J Guchelaar, S Wouda, G J Beukeveld, et al.
British Journal of Cancer|May 1, 1994
Prolonged continuous infusion of low-dose rIL-2R A Janssen, J Buter, T H The, et al.
Annals of Internal Medicine|June 15, 1989
Carboplatin and renal functionE F Smit, D T Sleijfer, S Meijer, et al.
Pageof 37

Showing results (91-100 of 369) with videos related to

Sort By:
Pageof 37
Cancer Research|January 15, 1990
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell lineS de Jong, J G Zijlstra, E G de Vries, et al.
Anticancer Research|September 1, 1995
Review of current clinical experience with prolonged (oral) etoposide in cancer treatmentR S de Jong, N H Mulder, D Dijksterhuis, et al.
The Netherlands Journal of Medicine|November 6, 1998
Treatment of special breast cancer patientsH de Graaf, P H Willemse, E G de Vries, et al.
Anticancer Research|December 29, 2000
Effect of specific or random c-DNA priming on sensitivity of tyrosinase nested RT-PCR: potential clinical relevanceA Calogero, G A Hospers, H Timmer-Bosscha, et al.
Journal of the National Cancer Institute|April 5, 1995
Role of the glutathione S-conjugate pump in cisplatin resistanceE G de Vries, M Müller, C Meijer, et al.
Anticancer Research|March 4, 2000
Selective use of preoperative radiotherapy in the treatment of cancer in the lower two thirds of the rectumJ M Ketel, R C Verschueren, N H Mulder, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1986
Evaluation of gastrointestinal toxicity following cytostatic chemotherapyJ M Smit, N H Mulder, D T Sleijfer, et al.
Journal of Pharmaceutical Sciences|May 1, 1992
Pharmacokinetics of parenteral 13-cis-retinoic acid formulations in ratsH J Guchelaar, S Wouda, G J Beukeveld, et al.
British Journal of Cancer|May 1, 1994
Prolonged continuous infusion of low-dose rIL-2R A Janssen, J Buter, T H The, et al.
Annals of Internal Medicine|June 15, 1989
Carboplatin and renal functionE F Smit, D T Sleijfer, S Meijer, et al.
Pageof 37